CATEGORIES: Applied Therapeutics | CMT Type - SORD Deficiency | CMT-Connect | CMT-Connect Webinars | Featured

SORD Webinar – Part 2 – Clinical Trial Update

by Courtney | Oct 9, 2022 | 0 comments

Learn more on this topic

HNF Partner: CMT-SORD Clinical Trial Update

by Courtney | May 20, 2025 | Applied Therapeutics, CMT Type - CMT1A, CMT Type - CMT1B, CMT Type - CMT1X, CMT Type - CMT2A, Featured, Industry | 0 Comments

CMT-SORD Clinical Trial Update Promising Results from the INSPIRE Study on Govorestat! We’re...

CMT Biobank: Particpate today!

by Courtney | May 19, 2025 | Community, Featured, Living with CMT, Upcoming Events | 0 Comments

Are you ready to help drive real progress in CMT research? The Hereditary Neuropathy Foundation...

Organileaf CBD & CMT Symptoms

by Courtney | Mar 31, 2025 | CMT-Connect Webinars, Webinars - Cannabis | 0 Comments

CBD Benefits for CMT Patients Ryan Whitman and Peter Durante shared their personal journeys,...

Become a Certified CMT-FOM Clinical Evaluator at the HNF Clinical Trial Readiness Summit

by Courtney | Feb 27, 2025 | Featured, Research | 0 Comments

Become a Certified CMT-FOM Clinical Evaluator at the HNF Clinical Trial Readiness Summit The...

NEW! Meet the CMT Dream Team!

by Courtney | Feb 26, 2025 | Faces of CMT, Featured, Living with CMT | 0 Comments

[dsm_image_carousel gallery_ids="285782,285783,285784,285785,285786,285787,285788"...

MDA Awards Grant to HNF for Groundbreaking Digital Wearable Study on CMT!

by Courtney | Feb 3, 2025 | Clinical Trials, CMT Summit, Featured, Patient-Focused Research, Pediatrics & CMT, Research | 0 Comments

Exciting news for the Charcot-Marie-Tooth (CMT) community! The Hereditary Neuropathy Foundation...

7 Reasons You Can’t Miss the Nashville CMT Summit

by Courtney | Jan 28, 2025 | CMT Summit, Fashion and Products, Featured, Newly Diagnosed, Nutrition, Patient-Focused Research, Pediatrics & CMT, Research, Research and Critical Trials | 0 Comments

Mark your calendars for April 24–26, 2025, because the Nashville CMT Summit is bringing the...

CMT Summit + Retreat 2025

by Courtney | Jan 16, 2025 | Advocacy, Awareness, CMT Summit, Featured, Nutrition, Podcasts, Research and Critical Trials, Webinars - Genetic Testing, Webinars - Newly Diagnosed, Webinars - Nutrition, Webinars - Podcasts, Webinars - Research and Clinical Trials | 2 Comments

CMT Summit + Retreat 2025: Uniting Patients, Researchers, Regulators, and Industry Leaders to...

Alesta Therapeutics Advances ALE2 to Target Rare Forms of CMT

by Courtney | Jan 13, 2025 | Clinical Trials, Featured, Industry, TRIAD | 0 Comments

Early preclinical research indicates that ALE2 could effectively slow or halt the progression of these debilitating symptoms, offering new hope for patients with these rare forms of CMT.

Welcome to the CMT Simplified Podcast by the HNF

by Courtney | Jan 7, 2025 | Awareness, Media, Podcasts, Research and Critical Trials, Webinars - Genetic Testing, Webinars - Newly Diagnosed, Webinars - Nutrition, Webinars - Podcasts, Webinars - Research and Clinical Trials | 0 Comments

CMT Simplified is here to make staying informed about Charcot-Marie-Tooth disease (CMT) easier...

WHAT IS CMT

TYPES OF CMT

PATIENT RESOURCES

CMT UPDATES

CMT CONNECT

CMT Research

TRIAD

GRIN PATIENT REGISTRY

PEDIATRICS & CMT

WHAT IS MITO

TYPES OF MITOS

MITO Faces

MITO Research

TRIAD - Mito

GRIN PATIENT REGISTRY

PEDIATRICS & MITO CMT

FDA

CLINICAL TRIALS

PATIENT-FOCUSED RESEARCH

EMERGING TECHNOLOGIES

GENETIC TESTING - CMT GENIE

MOVEMENT IS MEDICINE™

FACES OF CMT

INDUSTRY

HCPs/CENTERS OF EXCELLENCE

RESEARCH FUNDING

About HNF

OUR STORY

FOUNDATION LEADERSHIP

990's & ANNUAL REPORTS

Join Team CMT

Ways to Give

Amazon Wishlist

CMT Shop

GRIN Registry

Facebook Fundraiser

Celebrate your birthday with a purpose

Participate or Host an event

SORD Webinar – Part 2 – Clinical Trial Update

Learn more on this topic

Related Blog Posts

Join the conversation

Leave a Comment

0 Comments

Submit a Comment Cancel reply

Newsletter

Join for notifications on events, campaigns, & news

Success!